Early Life Interventions for Childhood Growth and Development In Tanzania

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,188

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

February 28, 2020

Study Completion Date

March 26, 2020

Conditions
MalnutritionStuntingCognitive DevelopmentEnteric Pathogens
Interventions
DRUG

Azithromycin Oral Liquid Product

Azithromycin 20 mg/kg administered by study personnel at 6, 9, 12 and 15 months

DRUG

Nitazoxanide Oral Suspension

Nitazoxanide 100 mg given twice daily for 3 days at 12 and 15 months

DIETARY_SUPPLEMENT

Nicotinamide

"Mothers in the nicotinamide arm will be given nicotinamide 250 mg daily from delivery through 6 months post-partum in capsule form.~Children in the nicotinamide arm will be given 100 mg/d in powder form between 6 and 18 months of age"

DRUG

Placebos

"Contain inert excipients only. Azithromycin placebo 20 mg/kg administered by study personnel at 6, 9, 12 and 15 months. Nitazoxanide placebo 100 mg given twice daily for 3 days at 12 and 15 months.~Mothers in the nicotinamide placebo arm will be given placebo 250 mg daily from delivery through 6 months post-partum in capsule form.~Children in the nicotinamide placebo arm will be given 100 mg/d of placebo in powder form between 6 and 18 months of age"

Trial Locations (1)

Unknown

Haydom Lutheran Hospital, Haydom

All Listed Sponsors
collaborator

University of Virginia

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Haydom Lutheran Hospital

OTHER

NCT03268902 - Early Life Interventions for Childhood Growth and Development In Tanzania | Biotech Hunter | Biotech Hunter